- China Apps Governance in 2019: Retrospec...2020-01-21
- Interim Measures in Mainland China Possi...2020-01-17
- Shanghai SAMR issued Anti-Monopoly Compl...2020-01-16
- China Stem Cell&Gene Therapy Opportuniti...2020-01-15
- Shanghai Issues Local Antitrust Complian...2020-01-03
- Highlights of China’s Officially Enacte...2019-11-01
- National Security Review in China: Ready...2019-09-26
- China Enacted New Drug Administration La...2019-08-28
- New Rules on Protection of Trade Secrets2019-08-28
- China's Green Light on Stem Cell, Gene D...2019-08-22
- Issues Relating to Occupational Health i...2019-08-07
- China’s SAMR Issues Interim Rules on Pr...2019-07-17
- New Rules on Exploitation of Human Genet...2019-06-18
- Establishment of “Unreliable Entity Lis...2019-06-11
- Quick View-Administrative Measures for D...2019-06-10
- China’s Unreliable Entity List, a Tit-f...2019-06-04
- Updated Guidance from the US Department ...2019-05-28
- A Guide for Foreign Investment in Online...2019-05-28
- Chinese or American Punishment? The Lega...2019-05-27
- China launches exclusion process for U.S...2019-05-17
Articles
Copyright © Zhong Lun Law Firm All rights Reserved ICP No. 05006255-1
For more details, please follow us on WeChat.
